A synthetic peptide inhibitor for α-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice

Melanoma Research

Volumn 9, Issue 2, 1999, Pages 105-114

  Fujisawa, N ^a   Hayashi, S ^b   Miller, E J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Growth inhibitor; Growth substances; Growth related oncogene; Interleukin 8; Melanoma

Indexed keywords

ALPHA CHEMOKINE; ANTILEUKINATE; CHEMOKINE RECEPTOR CXCR4; GROWTH FACTOR; GROWTH PROMOTOR; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 8; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR SUPPRESSOR GENE;

EID: 0032799920     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199904000-00001     Document Type: Article

References (41)

1. Liu T, Soong SJ. Epidemiology of malignant melanoma. Surg Clin North Am 1996; 76: 1205-1222.
2. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34: 839-847.
3. Legha, SS. The role of Interferon alpha in the treatment of metastatic melanoma. Semin Oncol 1997; 24: S4-24-S4-31.
4. Demierre MF, Koh HK. Adjuvant therapy for cutaneous malignant melanoma. J Am Acad Dermatol 1997; 36: 747-764.
5. Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK. Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. Cancer Res 1983; 43: 2106-2112.
6. Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK. Characterization of autostimulatory and transforming growth factors from human melanoma cells. Cancer Res 1985; 45: 6390-6394.
7. Richmond A, Thomas HG. Purification of melanoma growth stimulatory activity. J Cell Physiol 1986; 129: 375-384.
8. Hayashi S, Kurdowska A, Cohen AB, Stevens MD, Fujisawa N, Miller FJ. A synthetic peptide inhibitor for α-chemokines inhibits the growth of melanoma cell lines. J Clin Invest 1997; 99: 2581-2587.
9. Norgauer J, Metzner B, Schraufstätter I. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 1996; 157: 1132-1137.
10. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
11. Lindley I, Aschauer H, Seifert JM, Lam C, Brunowski W, Kownatzki E, Thelen M, Peveri P, Dewald B, vonTscharner V, Walz A, Baggiolini M. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biologic equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 1988; 85: 9199-9203.
12. Lawson DH, Thomas HG, Roy RG, Gordon DS, Chawla RK, Nixon DW, Richmond A. Preparation of a monoclonal antibody to a melanoma growth stimulatory activity released into serum-free culture medium by Hs294 malignant melanoma cells. J Cell Biochem 1987; 34: 169-185.
13. Schröder JM, Peterson NLM, Christophers E. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide-1/interleukin-8, a second neutrophil-activating protein with growth stimulatory activity. J Exp Med 1990; 171: 1091-1100.
14. Strieter RM, Polverini PJ, Arenberg DA, Waltz A, Opdenakker G, Damme JV, Kumkel SL. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leuk Biol 1992; 57: 752-762.
15. Baggioni M, Waltz A, Kunkel SK. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
16. Matsushima K, Oppenheim J. Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1: 2-13.
17. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E., Matthay MA. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Resp Dis 1992; 141: 1279-1284.
18. Miller EJ, Brelsford WG. Interleukin-8: the major neutrophil chemotaxin in a case of pseudogout. J Rheumatol 1993; 20: 1250-1252.
19. Koch AE, Polvelini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Stricter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258; 1738-1801.
20. Hu DE, Hori Y, Fan TPD. Interleukin-8 stimulates angiogenesis in rats. Inflammation 1993; 17: 135-143.
21. Arenberg DA, Kunkel SL, Polvelini PJ, Glass M, Burdick MD, Strieter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792-2802.
22. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280-1283.
23. Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M. Expression of transcripts for two interleukin-8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 1993; 294: 285-292.
24. Hayashi S, Kurdowska A, Miller EJ, Albright ME, Girten BE, Cohen AB. Synthetic hexa- and heptapeptides which inhibit IL-8 from binding to activating human blood neutrophils. J Immunol 1995; 154: 814-824.
25. Bregman MD, Meyskens FL. In vivo modulation of human and murine melanoma growth by prostanoid analogs. Prostaglandins 1983; 27: 17-26.
26. Gutman M, Singh K, Xie K, Bucana CD, Fidler IJ. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995; 55: 2470-2475.
27. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-I, a novel human malignant melanoma metastasis-suppresser gene. J Natl Cancer Inst 1996; 88: 1731-1737.
28. Sylvester I, Rankin JA, Yoshimura T, Tanaka S, Leonard EJ. Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Resp Dis 1990; 141: 683-686.
29. Miller EJ, Nagao S, Carr FK, Noble JM, Cohen AB. Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflamm Res 1996; 45: 386-392.
30. Mosmann T. Rapid calorimetric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
31. Bolton AE, Hunter WM. The labeling of proteins to high specific radioactivities by conjugation to a 125-I-containing acylating agent: application to the radio immunoassay. Biochem J 1973; 133: 529-539.
32. Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, Gilmore LB, Seftor REB, Nakajima M, Hendrix MJC, Characterization of a high invasive and spontaneously metastatic human malignant melanoma cell l.ine. Int J Cancer 1991; 47: 227-237.
33. Miele ME, Bennett F, Miller BE, Welch DR. Enhanced metastatic ability of TNF-α-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res 1994; 214: 231-241.
34. Parker SL, Tong T, Bolden TS, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5-27.
35. Legha SS. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with Interferon alfa and chemotherapy. Semin Oncol 1997; 24: S4-39-S4-43.
36. Kirkwood JM, Resnick GD, Cole BF. Efficacy, safety, and risk-benefit analysis of adjuvant Interferon alfa and chemotherapy. Semin Oncol 1997; 24: S4-16-S4-23.
37. Bergh JCS. Gene amplification in human lung cancer. Am Rev Resp Dis 1990; 142: S20-S26.
38. Leong SR, Lowman HB, Liu J, Shire S, Deforge LE, Gillece-Castro BL, McDowell R, Hébert CA. IL-8 single-chain homodimers and heterodimers: interactions with the chemokine receptors CXCR1, CXCR2, and DARC. Protein Sci 1997; 6: 609-617.
39. Schadendorf D, Möller A, Algermissen H, Worm M, Sticherling M, Czarnetzki BM. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993; 151: 2667-2675.
40. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242-3247.
41. Wang JM, Taraboletti G, Matsushima K, Damme JV, Mantovani A. Induction of hepatotactic migration of melanoma cells by neutrophil activating protein/1L-8. Biochem Biophys Res Commun 1990; 169: 165-170.